|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| C07K 14/705 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3436079 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17776766.2 |
| Date of filing the European patent application | 2017-03-31 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/025351 |
| Date | 2017-03-31 |
| (87) | Number | WO 2017/173256 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201662317258 P | 2016-04-01 | US |
| (72) |
WILTZIUS, Jed , US
|
| (73) |
Kite Pharma, Inc. ,
2400 Broadway, Santa Monica, CA 90404,
US
|
| (54) | CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE |
| CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE |